UBS Group AG Buys 859,584 Shares of Sabra Healthcare REIT, Inc. $SBRA

UBS Group AG raised its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 143.1% during the fourth quarter, HoldingsChannel.com reports. The fund owned 1,460,219 shares of the real estate investment trust’s stock after purchasing an additional 859,584 shares during the quarter. UBS Group AG’s holdings in Sabra Healthcare REIT were worth $27,657,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. Founders Capital Management bought a new stake in shares of Sabra Healthcare REIT in the 3rd quarter worth about $28,000. Danske Bank A S bought a new stake in shares of Sabra Healthcare REIT in the 3rd quarter worth about $30,000. Larson Financial Group LLC increased its holdings in shares of Sabra Healthcare REIT by 42.3% in the 3rd quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock worth $35,000 after buying an additional 553 shares during the last quarter. First Horizon Corp bought a new stake in shares of Sabra Healthcare REIT in the 4th quarter worth about $44,000. Finally, Covestor Ltd increased its holdings in shares of Sabra Healthcare REIT by 23,720.0% in the 3rd quarter. Covestor Ltd now owns 2,382 shares of the real estate investment trust’s stock worth $45,000 after buying an additional 2,372 shares during the last quarter. 99.40% of the stock is currently owned by institutional investors.

Sabra Healthcare REIT Price Performance

Shares of SBRA stock opened at $20.75 on Friday. The company has a debt-to-equity ratio of 0.96, a current ratio of 4.72 and a quick ratio of 4.72. The company has a market capitalization of $5.23 billion, a P/E ratio of 32.94, a P/E/G ratio of 1.66 and a beta of 0.67. The company’s 50-day simple moving average is $20.24 and its two-hundred day simple moving average is $19.41. Sabra Healthcare REIT, Inc. has a one year low of $17.08 and a one year high of $21.07.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, hitting analysts’ consensus estimates of $0.16. The business had revenue of $221.75 million for the quarter, compared to the consensus estimate of $209.20 million. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The company’s revenue for the quarter was up 20.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.37 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, equities analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.5 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 29th. Stockholders of record on Friday, May 15th will be paid a dividend of $0.30 per share. The ex-dividend date is Friday, May 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.8%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 190.48%.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the stock. Cantor Fitzgerald boosted their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a report on Tuesday, February 17th. Scotiabank boosted their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “sector perform” rating in a report on Monday, March 2nd. Weiss Ratings downgraded shares of Sabra Healthcare REIT from a “buy (a-)” rating to a “buy (b+)” rating in a report on Friday, May 1st. Citigroup boosted their target price on shares of Sabra Healthcare REIT from $21.00 to $24.00 and gave the stock a “buy” rating in a report on Wednesday, February 18th. Finally, UBS Group boosted their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a report on Thursday, February 19th. Five research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $22.00.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.